First Time Loading...
Search stocks here...
Dashboard Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator
Pricing About Contact Us
Sign Up Log in

Catalent Inc
NYSE:CTLT

Watchlist Manager
Catalent Inc Logo
Catalent Inc
NYSE:CTLT
Watchlist
Price: 37.23 USD +2.22% Market Closed
Updated: Jun 1, 2023
CTLT
/
Profitability
/
Operating Margin

Operating Margin

According to Catalent Inc's latest financial reports the company's operating margin is 14%.

13.8%
Current
14.6%
Average
7.6%
Industry
What is Operating Margin?

Operating Margin History

Statistics
Operating Margin

1 Year 3 Years 5 Years
Average 15.3% 14.6% 13.5%
Median 15.6% 14.3% 13.1%
Min 13.8% 11.3% 11.2%
Max 16.6% 17.1% 17.1%

History Chart
Operating Margin

Operating Margin Distribution

Operating Margin Distribution
Pharmaceuticals Industry

Operating Margin Across Competitors

Operating Margin Comparison
Catalent Inc Competitors

Country Company Market Cap Operating
Margin
US
Catalent Inc
NYSE:CTLT
6.7B USD
14%
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 551T JPY
-83%
US
Eli Lilly and Co
NYSE:LLY
408B USD
26%
US
Johnson & Johnson
NYSE:JNJ
405B USD
20%
DK
Novo Nordisk A/S
NYSE:NVO
361B USD
43%
US
Merck & Co Inc
NYSE:MRK
280B USD
32%
CH
Roche Holding AG
SIX:ROG
231B CHF
32%
UK
AstraZeneca PLC
LSE:AZN
181B GBP
19%
US
Pfizer Inc
NYSE:PFE
215B USD
35%
CH
Novartis AG
SIX:NOVN
185B CHF
25%
US
Bristol-Myers Squibb Co
NYSE:BMY
135B USD
25%
Catalent Inc
NYSE:CTLT
Country US
Market Cap 6.7B USD
Operating Margin
14%
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Country JP
Market Cap 776 551T JPY
Operating Margin
-83%
Eli Lilly and Co
NYSE:LLY
Country US
Market Cap 408B USD
Operating Margin
26%
Johnson & Johnson
NYSE:JNJ
Country US
Market Cap 405B USD
Operating Margin
20%
Novo Nordisk A/S
NYSE:NVO
Country DK
Market Cap 361B USD
Operating Margin
43%
Merck & Co Inc
NYSE:MRK
Country US
Market Cap 280B USD
Operating Margin
32%
Roche Holding AG
SIX:ROG
Country CH
Market Cap 231B CHF
Operating Margin
32%
AstraZeneca PLC
LSE:AZN
Country UK
Market Cap 181B GBP
Operating Margin
19%
Pfizer Inc
NYSE:PFE
Country US
Market Cap 215B USD
Operating Margin
35%
Novartis AG
SIX:NOVN
Country CH
Market Cap 185B CHF
Operating Margin
25%
Bristol-Myers Squibb Co
NYSE:BMY
Country US
Market Cap 135B USD
Operating Margin
25%

Profitability Report

View the profitability report to see the full profitability analysis for Catalent Inc.

Full Profitability Report

See Also

Summary
CTLT intrinsic value, competitors valuation, and company profile.
DCF Valuation
CTLT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CTLT stock valuation using valuation multiples.
Wall Street Estimates
CTLT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CTLT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Similar Stocks
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
=
Operating Profit
/
Revenue
ALPHA SPREAD
Join more than 54,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Pricing Terms of Service Privacy Policy Affiliate Program

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2023 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.